Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191939
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2023-12-20
Brief Title:
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
Sponsor:
Loyola Marymount University
Organization:
Loyola Marymount University
Study Overview
Official Title:
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this pilot clinical trial is to test a disease-tailored mindfulness-based intervention Mindful Self-Compassion for Lung Cancer MSC-LC in adults diagnosed with lung cancer who are experiencing stigma The current project seeks to
Evaluate preliminary evidence for the feasibility acceptability and preliminary efficacy of MSC-LC in reducing stigma for adults with lung cancer compared to a waitlist control condition
Elicit interventional impact not captured through quantitative measures with qualitative data from purposively sampled high responders and non-responders from the intervention condition
Participants will randomized to either the MSC-LC intervention a 10-week virtually-delivered group-based psychosocial intervention focused on the development of mindfulness and self-compassion skills or to a waitlist control group that receives a referral to an NCI list of helpful mental health resources in their community Researchers will compare the intervention and control groups to see if the MSC-LC intervention reduces lung cancer stigma and increases self-compassion
Evaluate preliminary evidence for the feasibility acceptability and preliminary efficacy of MSC-LC in reducing stigma for adults with lung cancer compared to a waitlist control condition
Elicit interventional impact not captured through quantitative measures with qualitative data from purposively sampled high responders and non-responders from the intervention condition
Participants will randomized to either the MSC-LC intervention a 10-week virtually-delivered group-based psychosocial intervention focused on the development of mindfulness and self-compassion skills or to a waitlist control group that receives a referral to an NCI list of helpful mental health resources in their community Researchers will compare the intervention and control groups to see if the MSC-LC intervention reduces lung cancer stigma and increases self-compassion
Detailed Description:
Lung cancer stigma ie perceived and internalized negative appraisal and devaluation associated with lung cancer is a pervasive problem experienced by the majority of lung cancer patients Notably experiences of lung cancer stigma are strongly associated with poorer quality of life and higher depressive symptoms Despite these associations there is a gap in the field regarding empirically supported patient-focused interventions that target the reduction of lung cancer stigma
Self-compassion ie directed kindness towards oneself in times of suffering is a protective psychosocial factor that has been targeted through intervention approaches to reduce shame and self-criticism in non-cancer samples Additionally higher self-compassion has been shown to attenuate the relationship between lung cancer stigma and depression suggesting that fostering self-compassion may be an effective intervention strategy to reduce lung cancer stigma Mindful Self-Compassion is an empirically supported 8-week psychosocial intervention demonstrated to increase self-compassion and reduce feelings of shame distress depression and anxiety in non-cancer samples However given several anticipated challenges associated with delivering Mindful Self-Compassion to lung cancer patients eg breathing challenges that arise during breath-focused meditations fatigue that interferes with attending 3-hour sessions the investigators developed an adapted version of the intervention Mindful Self-Compassion for Lung Cancer MSC-LC that is tailored to the needs of adults diagnosed with lung cancer addresses delivery challenges and targets the reduction of lung cancer stigma
This is a pilot trial examining the feasibility acceptability and preliminary efficacy of MSC-LC compared to waitlist control condition The central hypothesis is that MSC-LC will be demonstrate high feasibility and acceptability as well as preliminary efficacy in reducing lung cancer stigma and promoting self-compassion
Self-compassion ie directed kindness towards oneself in times of suffering is a protective psychosocial factor that has been targeted through intervention approaches to reduce shame and self-criticism in non-cancer samples Additionally higher self-compassion has been shown to attenuate the relationship between lung cancer stigma and depression suggesting that fostering self-compassion may be an effective intervention strategy to reduce lung cancer stigma Mindful Self-Compassion is an empirically supported 8-week psychosocial intervention demonstrated to increase self-compassion and reduce feelings of shame distress depression and anxiety in non-cancer samples However given several anticipated challenges associated with delivering Mindful Self-Compassion to lung cancer patients eg breathing challenges that arise during breath-focused meditations fatigue that interferes with attending 3-hour sessions the investigators developed an adapted version of the intervention Mindful Self-Compassion for Lung Cancer MSC-LC that is tailored to the needs of adults diagnosed with lung cancer addresses delivery challenges and targets the reduction of lung cancer stigma
This is a pilot trial examining the feasibility acceptability and preliminary efficacy of MSC-LC compared to waitlist control condition The central hypothesis is that MSC-LC will be demonstrate high feasibility and acceptability as well as preliminary efficacy in reducing lung cancer stigma and promoting self-compassion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R00CA256351 | NIH | None | httpsreporternihgovquickSearchR00CA256351 |